Citations

Mayo Clinic

Showing 10 of 108537 citations.

External Validation of the Modified Southwestern Aneurysm Severity Index in the Barrow Ruptured Aneurysm Trial Surgical Cohort
Labib, Mohamed A., Inoue, Mizuho, Kupanoff, Kristina, Abramov, Irakliy , Srinivasan, Visish M. , Spetzler, Robert F., Lawton, Michael T. , Lawton, Michael T , Catapano, Joshua S , Singh, Rohin , Scherschinski, Lea , Youn, Teddy S.

Neurosurgery | April 29, 2024 | Volume: 95 | Issue: 3 | Pages: 660-668

10.1227/neu.0000000000002959 | PMID 38682903 Get It

BACKGROUND AND OBJECTIVES: Predicting functional outcomes after surgical management of ruptured aneurysms is essential. This study sought to validate the modified Southwestern Aneurysm Severity Index (mSASI), which predicts functional outcomes 1 year after treatment. METHODS: The surgical arm of a randomized controlled trial, the Barrow Ruptured Aneurysm Trial, was used to validate the mSASI model. mSASI scores incorporating the Hunt and Hess scale, Non-Neurological American Society of Anesthesiologists Physical Classification Status, imaging findings, and other modifiers were assigned and evaluated against the Glasgow Outcome Scale (GOS) score at 1 year. The model's performance was assessed for discrimination and calibration. Similar evaluations were constructed using the modified Rankin Scale (mRS) as the 1-year functional outcome measurement. Long-term outcomes (3, 6, 10 years) were also evaluated. RESULTS: Of 280 clinical trial patients treated surgically, 242 met the inclusion criteria. The mean age was 54.1 ± 12.9 years; 31% were men. Favorable GOS score (4-5) and mRS score (0-2) at 1 year were observed in 73.6% and 66.1% of patients, respectively. The mSASI model predicted unfavorable GOS score at 1 year with fair to good discrimination (area under the curve = 0.75, 95% CI = 0.68-0.82) and accurate calibration (R 2 = 0.98). Similar results were obtained when mRS was used as the outcome measure (area under the curve = 0.75, 95% CI = 0.68-0.82; R 2 = 0.95). CONCLUSION: The mSASI model was externally validated in our cohort to predict functional outcomes using the GOS or mRS scores 1 year after surgery. This index may be used for prognosticating outcomes of patients undergoing surgery for ruptured aneurysms at short-term and long-term intervals.
Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)
Vazirani, Ravi , Hoyo, Rafael Sánchez-del , Viana‐Llamas, María C. , Raposeiras‐Roubín, Sergio , Romero, Rodolfo , Alfonso‐Rodríguez, Emilio , Uribarri, Aitor , Santoro, Francesco , Becerra‐Muñoz, Víctor Manuel , Pepe, Martino , Castro‐Mejía, Alex F. , Signes‐Costa, Jaime , González, Adelina , Marı́n, Francisco , López‐País, Javier , Cerrato, Enrico , Espejo‐Paeres, Carolina , Masjuan, Álvaro López, Velicki, Lazar , Núñez‐Gil, Iván J. , Hoyo, Rafael Sánchez-Del , Viana-Llamas, María C , Raposeiras-Roubin, Sergio , Alfonso-Rodríguez, Emilio , Santoro, Francesco , Becerra-Muñoz, Víctor , Castro Mejía, Alex Fernando , Marín, Francisco , Cerrato, Enrico , Espejo-Paeres, Carolina , Velicki, Lazar , Ramakrishna, Harish , Nuñez-Gil, Ivan Javier , Uribarri, Aitor , Feltes, Gisela , Vázquez-Cancela, Olalla , El‐Battrawy, Ibrahim , Fernández‐Ortíz, Antonio

Journal of Clinical Medicine | April 29, 2024 | Volume: 13 | Issue: 9 | Pages: 2596

10.3390/jcm13092596 | PMID 38731127 Get It

Background: Acute cardiac injury (ACI) after COVID-19 has been linked with unfavorable clinical outcomes, but data on the clinical impact of elevated cardiac troponin on discharge during follow-up are scarce. Our objective is to elucidate the clinical outcome of patients with elevated troponin on discharge after surviving a COVID-19 hospitalization. Methods: We conducted an analysis in the prospective registry HOPE-2 (NCT04778020). Only patients discharged alive were selected for analysis, and all-cause death on follow-up was considered as the primary endpoint. As a secondary endpoint, we established any long-term COVID-19 symptoms. HOPE-2 stopped enrolling patients on 31 December 2021, with 9299 patients hospitalized with COVID-19, of which 1805 were deceased during the acute phase. Finally, 2382 patients alive on discharge underwent propensity score matching by relevant baseline variables in a 1:3 fashion, from 56 centers in 8 countries. Results: Patients with elevated troponin experienced significantly higher all-cause death during follow-up (log-rank = 27.23, p < 0.001), and had a higher chance of experiencing long-term COVID-19 cardiovascular symptoms. Specifically, fatigue and dyspnea (57.7% and 62.8%, with p-values of 0.009 and <0.001, respectively) are among the most common. Conclusions: After surviving the acute phase, patients with elevated troponin on discharge present increased mortality and long-term COVID-19 symptoms over time, which is clinically relevant in follow-up visits.
Genetic counseling for the dystrophinopathies—Practice resource of the National Society of Genetic Counselors
Pickart, Angela M. , Martin, Ann , Gross, Brianna , Dellefave‐Castillo, Lisa , McCallen, Leslie , Nagaraj, Chinmayee B. , Schultz, Catherine P., Ulm, Elizabeth , Armstrong, Niki , Dellefave-Castillo, Lisa M , Pickart, Angela , Rippert, Alyssa L. , Schultz, Catherine

Journal of Genetic Counseling | April 29, 2024 | Volume: 34 | Issue: 1 | Pages: No page available

10.1002/jgc4.1892 | PMID 38682751 Get It

AbstractThe dystrophinopathies encompass the phenotypically variable forms of muscular dystrophy caused by pathogenic variants in the DMD gene. The dystrophinopathies include the most common inherited muscular dystrophy among 46,XY individuals, Duchenne muscular dystrophy, as well as Becker muscular dystrophy and other less common phenotypic variants. With increased access to and utilization of genetic testing in the diagnostic and carrier setting, genetic counselors and clinicians in diverse specialty areas may care for individuals with and carriers of dystrophinopathy. This practice resource was developed as a tool for genetic counselors and other health care professionals to support counseling regarding dystrophinopathies, including diagnosis, health risks and management, psychosocial needs, reproductive options, clinical trials, and treatment. Genetic testing efforts have enabled genotype/phenotype correlation in the dystrophinopathies, but have also revealed unexpected findings, further complicating genetic counseling for this group of conditions. Additionally, the therapeutic landscape for dystrophinopathies has dramatically changed with several FDA‐approved therapeutics, an expansive research pathway, and numerous clinical trials. Genotype–phenotype correlations are especially complex and genetic counselors' unique skill sets are useful in exploring and explaining this to families. Given the recent advances in diagnostic testing and therapeutics related to dystrophinopathies, this practice resource is a timely update for genetic counselors and other healthcare professionals involved in the diagnosis and care of individuals with dystrophinopathies.
Arsenic Exposure in Well Water From the Perspective of Patients and Providers
Jegen, Dominika , Maxson, Julie, Bernard, Matthew , Foss, Randy , Hidaka, Brandon H. , Passmore, Rachael , Sosso, Jessica , Stacey, Stephen K , Thacher, Tom D. , Fischer, Karen, Foss, Randy , Hidaka, Brandon , Passmore, Rachael , Thacher, Thomas D , Jegen, Dominika A , Fischer, Karen

Journal of Primary Care & Community Health | April 29, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241247984 | PMID 38682480 Get It

Background: Arsenic is a well-known toxin which may contaminate household water. It is harmful when ingested over prolonged periods of time. As a result, public health experts recommend that water should be screened and treated to prevent arsenic ingestion. In the United States, the responsibility of testing and treatment of private wells falls on homeowners. Despite recommendations for routine screening, this is rarely done. Objectives: To assess the prevalence of well water use in a Midwestern patient population, how patients and clinicians perceive the risks of arsenic in well water, and whether additional resources on well water testing are desired. These findings will be used to influence tools for clinicians regarding symptom and examination findings of chronic arsenic exposure and potentiate the distribution of informational resources on well water testing. Methods: Surveys were sent via email to all actively practicing primary care clinicians at the Mayo Clinic in the United States Midwest, and all active adult patients at the Mayo Clinic in the same region. Our team analyzed survey data to determine whether both patients and clinicians are aware of the health effects of chronic arsenic toxicity from well water, the need for routine well water testing and whether each group wants more information on the associated risks. Results: Both patients and primary care clinicians worry about arsenic exposure. Patients with well water are concerned about their water safety yet feel uninformed about testing options. Clinicians do not know how prevalent well water use is among their patients, feel uninformed about the chronic risks of arsenic exposure and the physical examination associated with it. Both groups unanimously want more information on testing options. Conclusions: Our findings show a significant reliance on well water use in the American Midwest, and unanimous support for the need for further well water testing information and resources for patients and their clinicians.
30-Day complications, operative time, and overnight admission following elective elbow arthroscopy
El-Najjar, Dany , Mehta, Apoorva, Gupta, Puneet , Peterson, Joel R. , Rogalski, Brandon L. , Saltzman, Bryan M. , Marigi, Erick M. , El-Najjar, Dany B , Gupta, Puneet , Jobin, Charles M. , Trofa, David P

Shoulder & Elbow | April 29, 2024 | Volume: 17 | Issue: 4 | Pages: 492-497

10.1177/17585732241249393 | PMID 39552679 Get It

Background Although arthroscopic procedures are generally considered safer than open procedures, they are not without complications. This study's purpose is to characterize patient demographics, medical complications, overnight admissions, and prolonged operative times for patients undergoing elective elbow arthroscopy using a national database. Methods This retrospective study used the ACS NSQIP database with data from 2015 to 2020. Patients undergoing elbow arthroscopy were identified, and those undergoing emergent surgery were excluded. Patient demographics, clinical characteristics, medical comorbidities, 30-day complications, overnight admission rates, and operative times were recorded and analyzed. Results Overall, 815 patients undergoing elective elbow arthroscopy were included. The mean age was 46.8 years. Mean BMI was 29.7 kg/m 2 , and 75.2% (n = 613) were male sex. The most common comorbidity was smoking (14.8%, n = 121). The cumulative complication rate was 2.5% (n = 20). The most common complication was surgical site infection (n = 7, 0.9%). 10.7% of patients required at least one overnight hospital stay. 20.2% of patients had a prolonged operative time ≥ 120 min. Conclusion Elbow arthroscopy is not without complications and morbidity despite being a minimally invasive procedure and advances made in surgical technique. Surgeons should use this information to facilitate shared-surgical decision making, preoperative patient counselling, and preoperative patient optimization.
Mini Review: Scientific Analysis of Radical S-Adenosylmethionine (SAM) Enzymes
Ariyaratne, Gallage H. D. Nipun

No container title available | April 29, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.26434/chemrxiv-2024-pswd0 Get It

The radical S-Adenosylmethionine (SAM) superfamily of enzymes catalyzes a diverse range of reactions ranging from hydrogen abstraction to complicated multistep reactions such as insertions and rearrangements. The reactions they catalyze are utilized in a broad range of biological functions such as cofactor and natural product biosynthesis, DNA repair, tRNA modification, metalloproteinase cluster formation, lipid metabolism and post-transcriptional and post-translational modifications. Sealed topographies of the radical SAM superfamily include a CXXXCXXC (CX3CX2C) motif that binds a [Fe4S4] cluster essential for the reductive cleavage of SAM. This is a review of recent developments in my understanding of the structure and mechanisms of these enzymes that, I gained through the research experience at Broderick’s group at Montana State University. I am currently affiliated with Mayo Clinic’s Physiology and Biomedical Engineering department as a predoctoral student.
Survival outcomes in pediatric patients with metastatic Ewing sarcoma who achieve a rapid complete response of pulmonary metastases
Reiter, Audra J. , Huang, Lynn , Craig, Brian T. , Davidoff, Andrew M. , Coggins, Jordan , Smith, Jasmine , Aldrink, Jennifer H. , Bergus, Katherine , MacArthur, Taleen A. , Polites, Stephanie F. , Boehmer, Chloé , Brungardt, Joseph G. , Arkin, Cameron, Gourmel, Antoine , Piché, Nelson , Wallace, Marshall, Liang, Jiancong , Lovvorn, Harold N. , Petroze, Robin T. , Gillies, Gwendolyn S. , Marquart, John , Becktell, Kerri , Favela, Juan , Rich, Barrie S. , Glick, Richard D. , Seemann, Natashia M. , Davidson, Jacob , Wilson, Claire A. , Roach, Jonathan P. , Doyle, Kathleen , Coakley, Brian A. , Emengo, Pamela, Merola, Pamela R., Grant, Christa N. , Tirumani, Anuritha, Dasgupta, Roshni , Wallace, Marshall W. , Aldrink, Jennifer H , Bergus, Katherine C , MacArthur, Taleen A , Malek, Marcus M , Kastenberg, Zachary J , Piche, Nelson , Becktell, Kerri , Seemann, Natashia M , Tracy, Elisabeth T , Lautz, Timothy , Dasgupta, Roshni , Arkin, Cameron , Talbot, Lindsay J , Malek, Marcus M. , Rinehardt, Hannah , Kastenberg, Zachary J. , Wallace, Marshall, Le, Hau D. , Brown, Erin G. , Tracy, Elisabeth T. , Moya‐Mendez, Mary E. , Lautz, Timothy B.

Pediatric Blood & Cancer | April 29, 2024 | Volume: 71 | Issue: 7 | Pages: No page available

10.1002/pbc.31026 | PMID 38679864 Get It

Abstract Purpose Our objectives were to compare overall survival (OS) and pulmonary relapse between patients with metastatic Ewing sarcoma (EWS) at diagnosis who achieve rapid complete response (RCR) and those with residual pulmonary nodules after induction chemotherapy (non‐RCR). Patients and methods This retrospective cohort study included children under 20 years with metastatic EWS treated from 2007 to 2020 at 19 institutions in the Pediatric Surgical Oncology Research Collaborative. Chi‐square tests were conducted for differences among groups. Kaplan–Meier curves were generated for OS and pulmonary relapse. Results Among 148 patients with metastatic EWS at diagnosis, 61 (41.2%) achieved RCR. Five‐year OS was 71.2% for patients who achieved RCR, and 50.2% for those without RCR ( p = .04), and in multivariable regression among patients with isolated pulmonary metastases, RCR (hazards ratio [HR] 0.42; 95% confidence interval [CI]: 0.17–0.99) and whole lung irradiation (WLI) (HR 0.35; 95% CI: 0.16–0.77) were associated with improved survival. Pulmonary relapse occurred in 57 (37%) patients, including 18 (29%) in the RCR and 36 (41%) in the non‐RCR groups ( p = .14). Five‐year pulmonary relapse rates did not significantly differ based on RCR (33.0%) versus non‐RCR (47.0%, p = .13), or WLI (38.8%) versus no WLI (46.0%, p = .32). Discussion Patients with EWS who had isolated pulmonary metastases at diagnosis had improved OS if they achieved RCR and received WLI, despite having no significant differences in rates of pulmonary relapse.
Predictive Value of Nasal Nitric Oxide for Diagnosing Eosinophilic Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis
Shin, Hyesoo , Hwang, Se Hwan , Kim, Do Hyun , Hwang, Se Hwan , Kim, Do Hyun , Stybayeva, Gulnaz

American Journal of Rhinology & Allergy | April 28, 2024 | Volume: 38 | Issue: 4 | Pages: 264-271

10.1177/19458924241251387 | PMID 38679754 Get It

Objectives The primary aim of this study was to assess disparities in nasal nitric oxide (NO) levels between individuals diagnosed with eosinophilic chronic rhinosinusitis (ECRS) and those without ECRS. The second aim was to ascertain the comparative predictive efficacy of these nasal NO levels for the presence of ECRS. Methods A systematic analysis was conducted on relevant studies that compared nasal NO levels in individuals with ECRS and those without. Furthermore, the discriminatory capacity of nasal NO in distinguishing ECRS from non-ECRS cohorts was quantified. The risk of bias across studies was evaluated utilizing the Newcastle-Ottawa scale. Results The comprehensive review encompassed a total of 5 studies involving 470 participants. Findings revealed that patients diagnosed with ECRS exhibited significantly higher levels of nasal NO, as measured in parts per billion (ppb), compared to their non-ECRS patients. The mean difference was 130.03 ppb (95% confidence interval: [66.30, 193.75], I2 = 58.7%). The diagnostic odds ratio for nasal NO in identifying ECRS was 9.29 ([5.85, 14.75], I2 = 26.4%). The area under the summary receiver operating characteristic curve was 0.82. The correlation between sensitivity and false positive rate was 0.53, suggesting a lack of heterogeneity. Sensitivity, specificity, negative predictive value, and positive predictive value were 69% ([0.55, 0.79], I2 = 77.0%), 83% ([0.73, 0.90], I 2 = 68.5%), 77% ([0.69, 0.83], I 2 = 50.1%), and 75% ([0.67, 0.82], I 2 = 41.5%), respectively. Conclusion Nasal NO has the potential as a noninvasive diagnostic measure and endotype tool for ECRS.
Introduction to the special issue on performance validity: what are we doing? What should we do?
Basso, Michael R. , Whiteside, Douglas M. , Combs, Dennis R. , Combs, Dennis , Whiteside, Douglas

Journal of Clinical and Experimental Neuropsychology | April 28, 2024 | Volume: 46 | Issue: 1 | Pages: 1-5

10.1080/13803395.2024.2347119 | PMID 38678395 Get It